Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Novel therapeutics for neurological disorders reported in recent patent literature

Dec. 2, 2005

Natural antidiabetic agent as a potential therapy for AD

Dec. 2, 2005

An oral nanoparticle formulation of taurine targeted for Alzheimer's

Dec. 2, 2005

Higher doses of phenserine may be efficacious in mild to moderate Alzheimer's disease

Dec. 2, 2005

Dosing begins in phase I study of NTx-265 for stroke

Dec. 2, 2005

Efficacy of ambroxol in chronic pain models: Nav1.8 Na+ channels as targets for analgesia

Dec. 2, 2005

Paliperidone ER submitted for FDA approval in schizophrenia

Dec. 1, 2005

European filing for bifeprunox delayed until 2008

Dec. 1, 2005

Enrollment completed in phase III study of CellCept for myasthenia gravis

Dec. 1, 2005

BioDelivery Sciences International plans trials for BEMA Long Acting Analgesic

Dec. 1, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...